Abstract
THIS laboratory has previously reported that β-diethylaminoethyl diphenylpropylacetate hydrochloride (SKF 525-A) potentiates the pharmacological activity of a variety of drugs by interfering with their rate of detoxication1,2. Recently, we have become interested in the potentiating effects of chlorpromazine and reserpine, drugs widely used for their tranquillizing effects. Chlorpromazine is reported to potentiate the action of a number of central depressant drugs, including barbiturates and ethanol3. We have been able to show that reserpine as well as chlorpromazine potentiates the hypnotic action of hexobarbitone and ethanol; and furthermore, that neither potentiating agent influences the rate of metabolic transformation of the hypnotics but acts presumably by increasing the sensitivity of the central nervous system.
Similar content being viewed by others
References
Axelrod, J., Reichenthal, J., and Brodie, B. B., J. Pharm. and Exp. Therap., 112, 49 (1954).
Cooper, J. R., Axelrod, J., and Brodie, B. B., J. Pharm. and Exp. Therap., 112, 55 (1954).
Courvoisier, S., Fournal, J., Ducrot, R., Kolsky, M., and Koetchet, P., Arch. int. Pharmacodyn., 92, 305 (1953).
Bucher, T., and Rodetski, M., Klin. Wochensch., 29, 615 (1951).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
BRODIE, B., SHORE, P., SILVER, S. et al. Potentiating Action of Chlorpromazine and Reserpine. Nature 175, 1133–1134 (1955). https://doi.org/10.1038/1751133a0
Issue Date:
DOI: https://doi.org/10.1038/1751133a0
- Springer Nature Limited
This article is cited by
-
Vesicular Integrity in Parkinson’s Disease
Current Neurology and Neuroscience Reports (2013)
-
On the mechanism of the synergistic effect of perazine and hexobarbital
Naunyn-Schmiedeberg's Archives of Pharmacology (1974)